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Introduction
“More than half a million women are diagnosed with cervical cancer and the 
disease results in over 300,000 deaths worldwide” (Cohen, Jhingran, Oaknin, & 
Denny, 2019, p. 169).  Studies have shown that the human papilloma virus (HPV) is 
what causes cervical cancer (Johnson, James, Marzan, & Armaos, 2019).  “Globally, 
70% of invasive cervical cancers are caused by infection with HPV 16 and 18” high-
risk subtypes (Kusumlata & Devi, 2019, p. 2).  Due to the lack of organized 
screening, lower income countries are more at risk of the disease. The rates of 
mortality have decreased over the past 30 years in higher-income countries due to 
HPV screening programs and vaccines (Cohen et al., 2019).  The Papanicolau (Pap) 
test is what healthcare providers use to screen for cervical cancer (Akinlotan et al., 
2017).  Prophylactic vaccination for HPV is considered the most preventative 
against cervical cancer (Kessler, 2017).  The two most common forms of cervical 
cancer are squamous cell carcinoma and adenocarcinoma (Johnson, et al., 2019). 
The stage of prognosis determines what treatment option is used, whether its 
surgery, chemotherapy, radiation or a combination of them all.  There is an 85% to 
90% success rate for early treatment for cervical cancer that’s confined to the 
cervix by having surgery to remove the cancer tissue (Kusumlata & Devi, 2019). 
Today’s healthcare providers have plenty of opportunities to impact the community 
on education and preventative measures for cervical cancer to reduce the number 
of incidences (Johnson et al., 2019).  
Underlying 
Pathophysiology
The cervix is located on the lower end of the uterus.  The “cervix connects the body of 
uterus to the vagina (birth canal)” (American Cancer Society, 2016).  There are two 
types of cervix cells which are glandular cells in the endocervix and squamous cells in 
the exocervix near the vagina side; Both cells meet in an area called the 
transformation zone, where the cells can change into pre-cancerous cells (American 
Cancer Society, 2016).  Squamous cell carcinomas and adenocarcinomas are the two 
most common cervical cancers.  
The HPV is contracted by having sexual intercourse.  When infected with HPV it can 
infect the cells of the cervix by producing E6 and E7 proteins that turn off tumor 
suppressor genes that would normally control cell growth, but if turned off, cells can 
now grow and can change into pre-cancerous cells (American Cancer Society, 2016).  
HPV is not the only risk factor to cause cervical cancer.  Other risk factors are smoking, 
overweight, poor diet that’s low in fruits and vegetables, long-term use of oral 
contraceptives, chlamydia, herpes simplex virus 2, multiple full-term pregnancies, and 
immune deficiency (Kessler, 2017).  
“HPV is the most common sexually transmitted infection worldwide and is the cause 
of nearly all cases of cervical cancer”;  Approximately 79 million men and women in 
the US are infected with HPV and about 14 million will become newly infected each 
year” (Kessler, 2017, p. 173).  Most people are unaware they have HPV due to being 
non-symptomatic.  Once infected with the virus the body’s immune system can usually 
clear it within 2 years.  The two most common high-risk HPV strands that cause pre-
cancerous lesions are types 16 and 18; The most common low-risk HPV strands that 
can cause genital warts are types 6 and 11 (Kessler, 2017).  
Image 1:  Cervix (Mayo Clinic, 2019).  
Significance of 
Pathophysiology 
It is important for healthcare providers to be familiar with methods of early prevention 
and detection strategies for cervical cancer incidences.  “Nearly 100% of cervical 
cancer cases test positive for HPV” (Kessler, 2017).  A way for both males and females 
to decrease their chances of being infected with HPV is by practicing safe sex practices 
whether by using a condom, limiting partners, or avoiding sex.  Another solution is 
getting the prophylactic HPV vaccination.  
The US Food and Drug Administration (FDA) have made three vaccines available which 
are Gardasil (4vHPV) in 2006, Cervarix (2vHPV) in 2009 and Gardasil 9 (9vHPV) in 2014 
(Kessler, 2017).  Each individual vaccine prevents an HPV type that is either cancerous 
causing or warts. 
• The most recent vaccine Gardasil 9 prevents HPV types “6, 11, 16, 18, 31, 33, 45, 
52, and 58” and is FDA approved for use in females ages 9 to 26, and males ages 
9 to 15 up to three doses can be administered (Kessler, 2017, p. 176). 
• “The world health organization recommends that the primary target population 
for the vaccination should be selected based on the age of imitation of sexual 
activity and the feasibility of reaching young adolescent girls through schools, 
health-care facilities, or community-based settings” (Swain & Parida, 2018, p. 
38).  
Cervical screening called the Papanicolaou cytology (Pap) tests is recommended 
starting at age 21 in the U.S. to screen for abnormal cells in the cervix (Johnson et al., 
2019).  Then at age 30, women should receive a pelvic exam annually, with a Pap tests 
every 3 years, and HPV testing every 5 years till the age of 65 (Johnson et al., 2019).  
Depending on the women’s risk factor for cervical cancer, the frequency of screenings 
could change per healthcare providers recommendation.   
Signs & Symptoms 
• The early stages of cervical cancer can be 
asymptomatic (Johnson et al., 2019).
• The “most common symptoms at presentation are 
“irregular or heavy vaginal bleeding, particularly 
following intercourse; Some women may present 
with vaginal discharge that may be watery, mucoid, 
or purulent and malodorous” (Johnson et al., 2019, p. 
167).  
• Advanced stages of cervical cancer are “pelvic or 
lower back pain; Bowel or bladder changes, such as 
pressure-related complaints” (Johnson et al., 2019).
• A pelvic exam should be performed with any 
symptom complaints previous mentioned.  There 
could be a visible lesion or normal cervix during the 
speculum exam, and the questionable lesion should 
be biopsied, with a Pap smear performed (Johnson et 
al., 2019).  
Image 2: 
Gardasil 9 Vial 
(Merck, 2015). 
(Cancer Institute NSW, 2019). 
Implications for Nursing Care 
Ways healthcare providers can encourage cervical cancer 
screenings and prevention is by educating not only the adults 
of the community, but the younger generation.  The parents of 
the younger generation need to be informed before their 
children become sexually active and contract HPV by 
unprotected intercourse.  Educating as early as 11 years of age 
is recommended (Kessler, 2017).  The HPV vaccinations needs 
to be encouraged not only for females but males who can also 
be infected with HPV.  There is a cost barrier for males to get 
vaccinated for HPV, so healthcare providers can help find 
clinics that offer reduced prices (Kessler, 2017). It is also 
important to help women overcome barriers they may have 
getting a Pap tests whether they are uninformed, anxiety, lack 
of insurance coverage, or transportation (Kessler, 2017).   The 
Health Belief Model and the Transtheoretical Model can be 
useful to healthcare providers to promote health behavior that 
will help increase screenings and vaccinations (Kessler, 2017).  
Knowledge alone does not promote behavior change, so 
healthcare providers need to be convincing (Kessler, 2017).  
Using the models mentioned can help better promote 
behavioral change.  Studies have shown that planned teaching 
programs are effective in improving cervical cancer knowledge 
to help women in early prevention and detection (Kusumlata 
& Devi, 2019).
Conclusion
Cervical cancer incidences have declined over the 
years in higher-income areas due to proper cervical 
cancer screenings such as the Pap tests, known risk 
factors such as HPV, and receiving the HPV 
prophylactic vaccine.  “It is the third most common 
cause of death worldwide for those women who live 
in low-resource or less developed countries” 
(Kessler, 2017, p. 172).  The proper education and 
resources for the community on preventing cervical 
cancer can help a community lower their risk.  
Women need to be aware of any abnormal 
symptoms to inform their healthcare provider and 
get screened.  Early detection is vital to preventing 
the cancer from spreading. 
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